FDA Inspection 1004804 — Delta Pharma, Inc.
The FDA completed an inspection of Delta Pharma, Inc. on February 23, 2017 in Ripley, MS. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 23, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ripley, MS (United States)